<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2018-01-31" version="219">
<accession>P02786</accession>
<accession>D3DXB0</accession>
<accession>Q1HE24</accession>
<accession>Q59G55</accession>
<accession>Q9UCN0</accession>
<accession>Q9UCU5</accession>
<accession>Q9UDF9</accession>
<accession>Q9UK21</accession>
<name>TFR1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transferrin receptor protein 1</fullName>
<shortName>TR</shortName>
<shortName>TfR</shortName>
<shortName>TfR1</shortName>
<shortName>Trfr</shortName>
</recommendedName>
<alternativeName>
<fullName>T9</fullName>
</alternativeName>
<alternativeName>
<fullName>p90</fullName>
</alternativeName>
<cdAntigenName>CD71</cdAntigenName>
<component>
<recommendedName>
<fullName>Transferrin receptor protein 1, serum form</fullName>
<shortName>sTfR</shortName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">TFRC</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1984" name="Nature" volume="311" first="675" last="678">
<title>Primary structure of human transferrin receptor deduced from the mRNA sequence.</title>
<authorList>
<person name="Schneider C."/>
<person name="Owen M.J."/>
<person name="Banville D."/>
<person name="Williams J.G."/>
</authorList>
<dbReference type="PubMed" id="6090955"/>
<dbReference type="DOI" id="10.1038/311675b0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT SER-142</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1984" name="Cell" volume="39" first="267" last="274">
<title>The human transferrin receptor gene: genomic organization, and the complete primary structure of the receptor deduced from a cDNA sequence.</title>
<authorList>
<person name="McClelland A."/>
<person name="Kuhn L.C."/>
<person name="Ruddle F.H."/>
</authorList>
<dbReference type="PubMed" id="6094009"/>
<dbReference type="DOI" id="10.1016/0092-8674(84)90004-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT SER-142</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Gene" volume="199" first="123" last="131">
<title>Exon/intron structure of the human transferrin receptor gene.</title>
<authorList>
<person name="Evans P."/>
<person name="Kemp J."/>
</authorList>
<dbReference type="PubMed" id="9358047"/>
<dbReference type="DOI" id="10.1016/S0378-1119(97)00356-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="thesis" date="1999" institute="University of Iowa" country="United States">
<title>Molecular and evolutionary studies of the transferrin receptor.</title>
<authorList>
<person name="Wheeler D.L."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2006-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Eye</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="19077" last="19081">
<title>Serum transferrin receptor is a truncated form of tissue receptor.</title>
<authorList>
<person name="Shih Y.J."/>
<person name="Baynes R.D."/>
<person name="Hudson B.G."/>
<person name="Flowers C.H."/>
<person name="Skikne B.S."/>
<person name="Cook J.D."/>
</authorList>
<dbReference type="PubMed" id="2229063"/>
</citation>
<scope>PROTEIN SEQUENCE OF 101-119 (STFR)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1991" name="Proc. Soc. Exp. Biol. Med." volume="197" first="416" last="423">
<title>Characterization of transferrin receptor released by K562 erythroleukemia cells.</title>
<authorList>
<person name="Baynes R.D."/>
<person name="Shih Y.J."/>
<person name="Hudson B.G."/>
<person name="Cook J.D."/>
</authorList>
<dbReference type="PubMed" id="1871153"/>
<dbReference type="DOI" id="10.3181/00379727-197-43276"/>
</citation>
<scope>PROTEIN SEQUENCE OF 101-123 (STFR)</scope>
<scope>CHARACTERIZATION</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1995" name="Biochem. J." volume="306" first="129" last="134">
<title>Identification of a novel form of the alpha 3 integrin subunit: covalent association with transferrin receptor.</title>
<authorList>
<person name="Coppolino M."/>
<person name="Migliorini M."/>
<person name="Argraves W.S."/>
<person name="Dedhar S."/>
</authorList>
<dbReference type="PubMed" id="7864799"/>
<dbReference type="DOI" id="10.1042/bj3060129"/>
</citation>
<scope>PROTEIN SEQUENCE OF 288-302; 694-708 AND 721-730</scope>
<source>
<tissue>Prostatic carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="1992" name="Nature" volume="358" first="764" last="768">
<title>Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.</title>
<authorList>
<person name="Chicz R.M."/>
<person name="Urban R.G."/>
<person name="Lane W.S."/>
<person name="Gorga J.C."/>
<person name="Stern L.J."/>
<person name="Vignali D.A.A."/>
<person name="Strominger J.L."/>
</authorList>
<dbReference type="PubMed" id="1380674"/>
<dbReference type="DOI" id="10.1038/358764a0"/>
</citation>
<scope>PROTEIN SEQUENCE OF 680-696</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1987" name="Cell" volume="49" first="423" last="431">
<title>Endocytosis of the transferrin receptor requires the cytoplasmic domain but not its phosphorylation site.</title>
<authorList>
<person name="Rothenberger S."/>
<person name="Iacopetta B.J."/>
<person name="Kuhn L.C."/>
</authorList>
<dbReference type="PubMed" id="3568132"/>
<dbReference type="DOI" id="10.1016/0092-8674(87)90295-9"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1987" name="EMBO J." volume="6" first="327" last="331">
<title>Identification of the intermolecular disulfide bonds of the human transferrin receptor and its lipid-attachment site.</title>
<authorList>
<person name="Jing S."/>
<person name="Trowbridge I.S."/>
</authorList>
<dbReference type="PubMed" id="3582362"/>
</citation>
<scope>PALMITOYLATION AT CYS-62 AND CYS-67</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1989" name="EMBO J." volume="8" first="2231" last="2240">
<title>Intermolecular disulfide bonds are not required for the expression of the dimeric state and functional activity of the transferrin receptor.</title>
<authorList>
<person name="Alvarez E."/>
<person name="Girones N."/>
<person name="Davis R.J."/>
</authorList>
<dbReference type="PubMed" id="2507316"/>
</citation>
<scope>MUTAGENESIS OF CYSTEINE RESIDUES INVOLVED IN INTERMOLECULAR BONDS</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1990" name="Biochem. J." volume="267" first="31" last="35">
<title>A point mutation in the cytoplasmic domain of the transferrin receptor inhibits endocytosis.</title>
<authorList>
<person name="Alvarez E."/>
<person name="Girones N."/>
<person name="Davis R.J."/>
</authorList>
<dbReference type="PubMed" id="2327986"/>
<dbReference type="DOI" id="10.1042/bj2670031"/>
</citation>
<scope>MUTAGENESIS OF TYR-20</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1990" name="J. Cell Biol." volume="110" first="283" last="294">
<title>Role of the human transferrin receptor cytoplasmic domain in endocytosis: localization of a specific signal sequence for internalization.</title>
<authorList>
<person name="Jing S."/>
<person name="Spencer T."/>
<person name="Miller K."/>
<person name="Hopkins C."/>
<person name="Trowbridge I.S."/>
</authorList>
<dbReference type="PubMed" id="2298808"/>
<dbReference type="DOI" id="10.1083/jcb.110.2.283"/>
</citation>
<scope>INTERNALIZATION SEQUENCE</scope>
<scope>MUTAGENESIS OF TYR-20</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1992" name="Glycobiology" volume="2" first="345" last="353">
<title>Presence of O-linked oligosaccharide on a threonine residue in the human transferrin receptor.</title>
<authorList>
<person name="Do S.-I."/>
<person name="Cummings R.D."/>
</authorList>
<dbReference type="PubMed" id="1421756"/>
<dbReference type="DOI" id="10.1093/glycob/2.4.345"/>
</citation>
<scope>GLYCOSYLATION AT THR-104</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1992" name="Glycobiology" volume="2" first="355" last="359">
<title>Identification of the O-linked glycosylation site of the human transferrin receptor.</title>
<authorList>
<person name="Hayes G.R."/>
<person name="Enns C.A."/>
<person name="Lucas J.J."/>
</authorList>
<dbReference type="PubMed" id="1421757"/>
<dbReference type="DOI" id="10.1093/glycob/2.4.355"/>
</citation>
<scope>GLYCOSYLATION AT THR-104</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="21686" last="21692">
<title>YTRF is the conserved internalization signal of the transferrin receptor, and a second YTRF signal at position 31-34 enhances endocytosis.</title>
<authorList>
<person name="Collawn J.F."/>
<person name="Lai A."/>
<person name="Domingo D.L."/>
<person name="Fitch M."/>
<person name="Hatton S."/>
<person name="Trowbridge I.S."/>
</authorList>
<dbReference type="PubMed" id="8408022"/>
</citation>
<scope>MUTAGENESIS OF 20-TYR--PHE-23; TYR-20; THR-21 AND PHE-23</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1995" name="Glycobiology" volume="5" first="227" last="232">
<title>The critical glycosylation site of human transferrin receptor contains a high-mannose oligosaccharide.</title>
<authorList>
<person name="Hayes G.R."/>
<person name="Williams A."/>
<person name="Costello C.E."/>
<person name="Enns C.A."/>
<person name="Lucas J.J."/>
</authorList>
<dbReference type="PubMed" id="7780197"/>
<dbReference type="DOI" id="10.1093/glycob/5.2.227"/>
</citation>
<scope>STRUCTURE OF CARBOHYDRATES ON ASN-727</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1996" name="Eur. J. Biochem." volume="235" first="9" last="17">
<title>Functional analysis of human/chicken transferrin receptor chimeras indicates that the carboxy-terminal region is important for ligand binding.</title>
<authorList>
<person name="Buchegger F."/>
<person name="Trowbridge I.S."/>
<person name="Liu L.F."/>
<person name="White S."/>
<person name="Collawn J.F."/>
</authorList>
<dbReference type="PubMed" id="8631371"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1996.0009u.x"/>
</citation>
<scope>IDENTIFICATION OF LIGAND-BINDING DOMAIN</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1999" name="Biochem. J." volume="341" first="11" last="14">
<title>A conserved RGD (Arg-Gly-Asp) motif in the transferrin receptor is required for binding to transferrin.</title>
<authorList>
<person name="Dubljevic V."/>
<person name="Sali A."/>
<person name="Goding J.W."/>
</authorList>
<dbReference type="PubMed" id="10377239"/>
<dbReference type="DOI" id="10.1042/bj3410011"/>
</citation>
<scope>MUTAGENESIS OF ARG-646; GLY-647 AND ASP-648</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2001" name="J. Mol. Biol." volume="313" first="385" last="397">
<title>Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites.</title>
<authorList>
<person name="West A.P. Jr."/>
<person name="Giannetti A.M."/>
<person name="Herr A.B."/>
<person name="Bennett M.J."/>
<person name="Nangiana J.S."/>
<person name="Pierce J.R."/>
<person name="Weiner L.P."/>
<person name="Snow P.M."/>
<person name="Bjorkman P.J."/>
</authorList>
<dbReference type="PubMed" id="11800564"/>
<dbReference type="DOI" id="10.1006/jmbi.2001.5048"/>
</citation>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2005" name="Cell" volume="123" first="875" last="888">
<title>TTP specifically regulates the internalization of the transferrin receptor.</title>
<authorList>
<person name="Tosoni D."/>
<person name="Puri C."/>
<person name="Confalonieri S."/>
<person name="Salcini A.E."/>
<person name="De Camilli P."/>
<person name="Tacchetti C."/>
<person name="Di Fiore P.P."/>
</authorList>
<dbReference type="PubMed" id="16325581"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.10.021"/>
</citation>
<scope>INTERACTION WITH SH3BP4</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="J. Proteome Res." volume="5" first="3135" last="3144">
<title>Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.</title>
<authorList>
<person name="Chi A."/>
<person name="Valencia J.C."/>
<person name="Hu Z.-Z."/>
<person name="Watabe H."/>
<person name="Yamaguchi H."/>
<person name="Mangini N.J."/>
<person name="Huang H."/>
<person name="Canfield V.A."/>
<person name="Cheng K.C."/>
<person name="Yang F."/>
<person name="Abe R."/>
<person name="Yamagishi S."/>
<person name="Shabanowitz J."/>
<person name="Hearing V.J."/>
<person name="Wu C."/>
<person name="Appella E."/>
<person name="Hunt D.F."/>
</authorList>
<dbReference type="PubMed" id="17081065"/>
<dbReference type="DOI" id="10.1021/pr060363j"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Nature" volume="446" first="92" last="96">
<title>Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses.</title>
<authorList>
<person name="Radoshitzky S.R."/>
<person name="Abraham J."/>
<person name="Spiropoulou C.F."/>
<person name="Kuhn J.H."/>
<person name="Nguyen D."/>
<person name="Li W."/>
<person name="Nagel J."/>
<person name="Schmidt P.J."/>
<person name="Nunberg J.H."/>
<person name="Andrews N.C."/>
<person name="Farzan M."/>
<person name="Choe H."/>
</authorList>
<dbReference type="PubMed" id="17287727"/>
<dbReference type="DOI" id="10.1038/nature05539"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH MACHUPO VIRUS PROTEIN GLYCOPROTEIN COMPLEX</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="2664" last="2669">
<title>Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses.</title>
<authorList>
<person name="Radoshitzky S.R."/>
<person name="Kuhn J.H."/>
<person name="Spiropoulou C.F."/>
<person name="Albarino C.G."/>
<person name="Nguyen D.P."/>
<person name="Salazar-Bravo J."/>
<person name="Dorfman T."/>
<person name="Lee A.S."/>
<person name="Wang E."/>
<person name="Ross S.R."/>
<person name="Choe H."/>
<person name="Farzan M."/>
</authorList>
<dbReference type="PubMed" id="18268337"/>
<dbReference type="DOI" id="10.1073/pnas.0709254105"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH GUANARITO VIRUS GLYCOPROTEIN COMPLEX</scope>
<scope>INTERACTION WITH JUNIN VIRUS GLYCOPROTEIN COMPLEX</scope>
<scope>INTERACTION WITH MACHUPO VIRUS GLYCOPROTEIN COMPLEX</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251 AND ASN-727</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Nat. Biotechnol." volume="27" first="378" last="386">
<title>Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.</title>
<authorList>
<person name="Wollscheid B."/>
<person name="Bausch-Fluck D."/>
<person name="Henderson C."/>
<person name="O'Brien R."/>
<person name="Bibel M."/>
<person name="Schiess R."/>
<person name="Aebersold R."/>
<person name="Watts J.D."/>
</authorList>
<dbReference type="PubMed" id="19349973"/>
<dbReference type="DOI" id="10.1038/nbt.1532"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1998" name="Structure" volume="6" first="1235" last="1243">
<title>Structural model of phospholipid-reconstituted human transferrin receptor derived by electron microscopy.</title>
<authorList>
<person name="Fuchs H."/>
<person name="Luecken W."/>
<person name="Tauber R."/>
<person name="Engel A."/>
</authorList>
<dbReference type="PubMed" id="9782058"/>
<dbReference type="DOI" id="10.1016/S0969-2126(98)00124-5"/>
</citation>
<scope>ELECTRON MICROSCOPY</scope>
<scope>PHOSPHORYLATION AT SER-24</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1999" name="Science" volume="286" first="779" last="782">
<title>Crystal structure of the ectodomain of human transferrin receptor.</title>
<authorList>
<person name="Lawrence C.M."/>
<person name="Ray S."/>
<person name="Babyonyshev M."/>
<person name="Galluser R."/>
<person name="Borhani D.W."/>
<person name="Harrison S.C."/>
</authorList>
<dbReference type="PubMed" id="10531064"/>
<dbReference type="DOI" id="10.1126/science.286.5440.779"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 121-760</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2001" name="Hum. Genet." volume="109" first="393" last="401">
<title>Identification of 96 single nucleotide polymorphisms in eight genes involved in iron metabolism: efficiency of bioinformatic extraction compared with a systematic sequencing approach.</title>
<authorList>
<person name="Douabin-Gicquel V."/>
<person name="Soriano N."/>
<person name="Ferran H."/>
<person name="Wojcik F."/>
<person name="Palierne E."/>
<person name="Tamim S."/>
<person name="Jovelin T."/>
<person name="McKie A.T."/>
<person name="Le Gall J.-Y."/>
<person name="David V."/>
<person name="Mosser J."/>
</authorList>
<dbReference type="PubMed" id="11702220"/>
<dbReference type="DOI" id="10.1007/s004390100599"/>
</citation>
<scope>VARIANT SER-142</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2016" name="Nat. Genet." volume="48" first="74" last="78">
<title>A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency.</title>
<authorList>
<person name="Jabara H.H."/>
<person name="Boyden S.E."/>
<person name="Chou J."/>
<person name="Ramesh N."/>
<person name="Massaad M.J."/>
<person name="Benson H."/>
<person name="Bainter W."/>
<person name="Fraulino D."/>
<person name="Rahimov F."/>
<person name="Sieff C."/>
<person name="Liu Z.J."/>
<person name="Alshemmari S.H."/>
<person name="Al-Ramadi B.K."/>
<person name="Al-Dhekri H."/>
<person name="Arnaout R."/>
<person name="Abu-Shukair M."/>
<person name="Vatsayan A."/>
<person name="Silver E."/>
<person name="Ahuja S."/>
<person name="Davies E.G."/>
<person name="Sola-Visner M."/>
<person name="Ohsumi T.K."/>
<person name="Andrews N.C."/>
<person name="Notarangelo L.D."/>
<person name="Fleming M.D."/>
<person name="Al-Herz W."/>
<person name="Kunkel L.M."/>
<person name="Geha R.S."/>
</authorList>
<dbReference type="PubMed" id="26642240"/>
<dbReference type="DOI" id="10.1038/ng.3465"/>
</citation>
<scope>INVOLVEMENT IN IMD46</scope>
<scope>VARIANT IMD46 HIS-20</scope>
<scope>CHARACTERIZATION OF VARIANT IMD46 HIS-20</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH STEAP3</scope>
</reference>
<comment type="function">
<text evidence="10 27 28">Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes. Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system (By similarity). A second ligand, the heditary hemochromatosis protein HFE, competes for binding with transferrin for an overlapping C-terminal binding site. Positively regulates T and B cell proliferation through iron uptake (PubMed:26642240).</text>
</comment>
<comment type="function">
<text evidence="21 22">(Microbial infection) Acts as a receptor for new-world arenaviruses: Guanarito, Junin and Machupo virus.</text>
</comment>
<comment type="subunit">
<text evidence="18 27">Homodimer; disulfide-linked. Binds one transferrin or HFE molecule per subunit. Binds the HLA class II histocompatibility antigen, DR1. Interacts with SH3BP3. Interacts with STEAP3; facilitates TFRC endocytosis in erythroid precursor cells (PubMed:26642240).</text>
</comment>
<comment type="subunit">
<text evidence="21 22">(Microbial infection) Interacts with Guanarito, Junin and Machupo arenavirus glycoprotein complex (PubMed:17287727, PubMed:18268337).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355727"/>
<interactant intactId="EBI-355727"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355727"/>
<interactant intactId="EBI-714423">
<id>P02768</id>
<label>ALB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355727"/>
<interactant intactId="EBI-6942903">
<id>Q96BA8</id>
<label>CREB3L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355727"/>
<interactant intactId="EBI-713259">
<id>P02794</id>
<label>FTH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355727"/>
<interactant intactId="EBI-1028850">
<id>Q30201</id>
<label>HFE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355727"/>
<interactant intactId="EBI-15489346">
<id>Q30201-1</id>
<label>HFE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355727"/>
<interactant intactId="EBI-347996">
<id>O43765</id>
<label>SGTA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355727"/>
<interactant intactId="EBI-1049513">
<id>Q9P0V3</id>
<label>SH3BP4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355727"/>
<interactant intactId="EBI-714319">
<id>P02787</id>
<label>TF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="20">Cell membrane</location>
<topology evidence="20">Single-pass type II membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="20">Melanosome</location>
</subcellularLocation>
<text evidence="20">Identified by mass spectrometry in melanosome fractions from stage I to stage IV.</text>
</comment>
<comment type="subcellular location">
<molecule>Transferrin receptor protein 1, serum form</molecule>
<subcellularLocation>
<location evidence="20">Secreted</location>
</subcellularLocation>
</comment>
<comment type="induction">
<text>Regulated by cellular iron levels through binding of the iron regulatory proteins, IRP1 and IRP2, to iron-responsive elements in the 3'-UTR. Up-regulated upon mitogenic stimulation.</text>
</comment>
<comment type="PTM">
<text evidence="16 17 19 23 24 29">N- and O-glycosylated, phosphorylated and palmitoylated. The serum form is only glycosylated.</text>
</comment>
<comment type="PTM">
<text>Proteolytically cleaved on Arg-100 to produce the soluble serum form (sTfR).</text>
</comment>
<comment type="PTM">
<text evidence="29">Palmitoylated on both Cys-62 and Cys-67. Cys-62 seems to be the major site of palmitoylation.</text>
</comment>
<comment type="disease" evidence="27">
<disease id="DI-04634">
<name>Immunodeficiency 46</name>
<acronym>IMD46</acronym>
<description>An autosomal recessive primary immunodeficiency disorder characterized by early-onset chronic diarrhea, recurrent infections, hypo- or agammaglobulinemia, normal lymphocyte counts, intermittent neutropenia, and intermittent thrombocytopenia.</description>
<dbReference type="MIM" id="616740"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Serum transferrin receptor (sTfR) is used as a means of detecting erythropoietin (EPO) misuse by athletes and as a diagnostic test for anemia resulting from a number of conditions including rheumatoid arthritis, pregnancy, irritable bowel syndrome and in HIV patients.</text>
</comment>
<comment type="miscellaneous">
<text>Canine and feline parvoviruses bind human and feline transferrin receptors and use these receptors to enter and infect cells.</text>
</comment>
<comment type="similarity">
<text evidence="34">Belongs to the peptidase M28 family. M28B subfamily.</text>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAD92491" version="1"/>
</conflict>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/TFRCID259ch3q29.html"/>
</comment>
<dbReference type="EMBL" id="X01060">
<property type="protein sequence ID" value="CAA25527.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M11507">
<property type="protein sequence ID" value="AAA61153.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF187320">
<property type="protein sequence ID" value="AAF04564.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB209254">
<property type="protein sequence ID" value="BAD92491.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ496099">
<property type="protein sequence ID" value="ABF47088.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471191">
<property type="protein sequence ID" value="EAW53670.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471191">
<property type="protein sequence ID" value="EAW53673.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001188">
<property type="protein sequence ID" value="AAH01188.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3312.1"/>
<dbReference type="PIR" id="A93343">
<property type="entry name" value="JXHU"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121620.1">
<property type="nucleotide sequence ID" value="NM_001128148.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001300894.1">
<property type="nucleotide sequence ID" value="NM_001313965.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001300895.1">
<property type="nucleotide sequence ID" value="NM_001313966.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003225.2">
<property type="nucleotide sequence ID" value="NM_003234.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.529618"/>
<dbReference type="PDB" id="1CX8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C/D/E/F/G/H=122-760"/>
</dbReference>
<dbReference type="PDB" id="1DE4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="C/F/I=121-760"/>
</dbReference>
<dbReference type="PDB" id="1SUV">
<property type="method" value="EM"/>
<property type="resolution" value="7.50"/>
<property type="chains" value="A/B=122-760"/>
</dbReference>
<dbReference type="PDB" id="2NSU">
<property type="method" value="EM"/>
<property type="resolution" value="27.00"/>
<property type="chains" value="A/B=122-760"/>
</dbReference>
<dbReference type="PDB" id="3KAS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=121-760"/>
</dbReference>
<dbReference type="PDB" id="3S9L">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.22"/>
<property type="chains" value="A/B=120-760"/>
</dbReference>
<dbReference type="PDB" id="3S9M">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.32"/>
<property type="chains" value="A/B=120-760"/>
</dbReference>
<dbReference type="PDB" id="3S9N">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A/B=120-760"/>
</dbReference>
<dbReference type="PDBsum" id="1CX8"/>
<dbReference type="PDBsum" id="1DE4"/>
<dbReference type="PDBsum" id="1SUV"/>
<dbReference type="PDBsum" id="2NSU"/>
<dbReference type="PDBsum" id="3KAS"/>
<dbReference type="PDBsum" id="3S9L"/>
<dbReference type="PDBsum" id="3S9M"/>
<dbReference type="PDBsum" id="3S9N"/>
<dbReference type="ProteinModelPortal" id="P02786"/>
<dbReference type="SMR" id="P02786"/>
<dbReference type="BioGrid" id="112895">
<property type="interactions" value="84"/>
</dbReference>
<dbReference type="CORUM" id="P02786"/>
<dbReference type="DIP" id="DIP-2736N"/>
<dbReference type="ELM" id="P02786"/>
<dbReference type="IntAct" id="P02786">
<property type="interactions" value="72"/>
</dbReference>
<dbReference type="MINT" id="MINT-4999032"/>
<dbReference type="STRING" id="9606.ENSP00000353224"/>
<dbReference type="DrugBank" id="DB09412">
<property type="generic name" value="Gallium citrate Ga-67"/>
</dbReference>
<dbReference type="DrugBank" id="DB05260">
<property type="generic name" value="Gallium nitrate"/>
</dbReference>
<dbReference type="MEROPS" id="M28.972"/>
<dbReference type="TCDB" id="9.B.229.1.1">
<property type="family name" value="the transferrin receptor, cd71, (tfr) family"/>
</dbReference>
<dbReference type="iPTMnet" id="P02786"/>
<dbReference type="PhosphoSitePlus" id="P02786"/>
<dbReference type="SwissPalm" id="P02786"/>
<dbReference type="UniCarbKB" id="P02786"/>
<dbReference type="BioMuta" id="TFRC"/>
<dbReference type="DMDM" id="108935939"/>
<dbReference type="EPD" id="P02786"/>
<dbReference type="MaxQB" id="P02786"/>
<dbReference type="PaxDb" id="P02786"/>
<dbReference type="PeptideAtlas" id="P02786"/>
<dbReference type="PRIDE" id="P02786"/>
<dbReference type="DNASU" id="7037"/>
<dbReference type="Ensembl" id="ENST00000360110">
<property type="protein sequence ID" value="ENSP00000353224"/>
<property type="gene ID" value="ENSG00000072274"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000392396">
<property type="protein sequence ID" value="ENSP00000376197"/>
<property type="gene ID" value="ENSG00000072274"/>
</dbReference>
<dbReference type="GeneID" id="7037"/>
<dbReference type="KEGG" id="hsa:7037"/>
<dbReference type="UCSC" id="uc003fvz.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7037"/>
<dbReference type="DisGeNET" id="7037"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000072274.12"/>
<dbReference type="GeneCards" id="TFRC"/>
<dbReference type="HGNC" id="HGNC:11763">
<property type="gene designation" value="TFRC"/>
</dbReference>
<dbReference type="HPA" id="CAB000153"/>
<dbReference type="HPA" id="HPA028598"/>
<dbReference type="MalaCards" id="TFRC"/>
<dbReference type="MIM" id="190010">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616740">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P02786"/>
<dbReference type="OpenTargets" id="ENSG00000072274"/>
<dbReference type="PharmGKB" id="PA36478"/>
<dbReference type="eggNOG" id="KOG2195">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG2234">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00550000074421"/>
<dbReference type="HOVERGEN" id="HBG023177"/>
<dbReference type="InParanoid" id="P02786"/>
<dbReference type="KO" id="K06503"/>
<dbReference type="OMA" id="DNSHVEM"/>
<dbReference type="OrthoDB" id="EOG091G02ZM"/>
<dbReference type="PhylomeDB" id="P02786"/>
<dbReference type="TreeFam" id="TF312981"/>
<dbReference type="Reactome" id="R-HSA-432722">
<property type="pathway name" value="Golgi Associated Vesicle Biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856825">
<property type="pathway name" value="Cargo recognition for clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-917977">
<property type="pathway name" value="Transferrin endocytosis and recycling"/>
</dbReference>
<dbReference type="SIGNOR" id="P02786"/>
<dbReference type="ChiTaRS" id="TFRC">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P02786"/>
<dbReference type="GeneWiki" id="TFRC"/>
<dbReference type="GenomeRNAi" id="7037"/>
<dbReference type="PRO" id="PR:P02786"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000072274"/>
<dbReference type="CleanEx" id="HS_TFRC"/>
<dbReference type="ExpressionAtlas" id="P02786">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P02786">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0072562">
<property type="term" value="C:blood microparticle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005905">
<property type="term" value="C:clathrin-coated pit"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030665">
<property type="term" value="C:clathrin-coated vesicle membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903561">
<property type="term" value="C:extracellular vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990712">
<property type="term" value="C:HFE-transferrin receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042470">
<property type="term" value="C:melanosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0055037">
<property type="term" value="C:recycling endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003725">
<property type="term" value="F:double-stranded RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004998">
<property type="term" value="F:transferrin receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0033570">
<property type="term" value="F:transferrin transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006879">
<property type="term" value="P:cellular iron ion homeostasis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0035690">
<property type="term" value="P:cellular response to drug"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1990830">
<property type="term" value="P:cellular response to leukemia inhibitory factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097286">
<property type="term" value="P:iron ion import"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030316">
<property type="term" value="P:osteoclast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030890">
<property type="term" value="P:positive regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045780">
<property type="term" value="P:positive regulation of bone resorption"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045830">
<property type="term" value="P:positive regulation of isotype switching"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042102">
<property type="term" value="P:positive regulation of T cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031623">
<property type="term" value="P:receptor internalization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033572">
<property type="term" value="P:transferrin transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd02128">
<property type="entry name" value="PA_TfR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.930.40">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR003137">
<property type="entry name" value="PA_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR007484">
<property type="entry name" value="Peptidase_M28"/>
</dbReference>
<dbReference type="InterPro" id="IPR029513">
<property type="entry name" value="TfR"/>
</dbReference>
<dbReference type="InterPro" id="IPR007365">
<property type="entry name" value="TFR-like_dimer_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036757">
<property type="entry name" value="TFR-like_dimer_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR037324">
<property type="entry name" value="TfR1/2_PA"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10404:SF26">
<property type="entry name" value="PTHR10404:SF26"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02225">
<property type="entry name" value="PA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04389">
<property type="entry name" value="Peptidase_M28"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04253">
<property type="entry name" value="TFR_dimer"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47672">
<property type="entry name" value="SSF47672"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0254">Endocytosis</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="chain" description="Transferrin receptor protein 1" id="PRO_0000174132">
<location>
<begin position="1"/>
<end position="760"/>
</location>
</feature>
<feature type="chain" description="Transferrin receptor protein 1, serum form" id="PRO_0000292265">
<location>
<begin position="101"/>
<end position="760"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="12">
<location>
<begin position="1"/>
<end position="67"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type II membrane protein" evidence="12">
<location>
<begin position="68"/>
<end position="88"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="12">
<location>
<begin position="89"/>
<end position="760"/>
</location>
</feature>
<feature type="domain" description="PA">
<location>
<begin position="223"/>
<end position="313"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with SH3BP4" evidence="18">
<location>
<begin position="1"/>
<end position="67"/>
</location>
</feature>
<feature type="region of interest" description="Ligand-binding">
<location>
<begin position="569"/>
<end position="760"/>
</location>
</feature>
<feature type="short sequence motif" description="Endocytosis signal">
<location>
<begin position="20"/>
<end position="23"/>
</location>
</feature>
<feature type="short sequence motif" description="Stop-transfer sequence">
<location>
<begin position="58"/>
<end position="61"/>
</location>
</feature>
<feature type="short sequence motif" description="Cell attachment site; required for binding to transferrin">
<location>
<begin position="646"/>
<end position="648"/>
</location>
</feature>
<feature type="site" description="Cleavage; by trypsin; to produce soluble form">
<location>
<begin position="100"/>
<end position="101"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="10"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="19"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="8">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="33">
<location>
<position position="24"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="29">
<location>
<position position="62"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="35">
<location>
<position position="67"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" id="CAR_000072" evidence="16 17">
<location>
<position position="104"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 3 14 19 23 24">
<location>
<position position="251"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 4 5 6 14">
<location>
<position position="317"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" id="CAR_000173" evidence="1 3 14 23">
<location>
<position position="727"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain">
<location>
<position position="89"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain">
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD46; increases protein expression; increases cell surface expression on T and B cells; increases soluble form level; impairs receptor internalization; impairs transferrin transport; impairs T and B cell proliferation as well as B cell class-switching; interacts with STEAP3; doesn't affect receptor internalization in erythroid precursor cells; dbSNP:rs863225436." id="VAR_076365" evidence="27">
<original>Y</original>
<variation>H</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs3817672." id="VAR_012737" evidence="15 30 31">
<original>G</original>
<variation>S</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41301381." id="VAR_051806">
<original>L</original>
<variation>V</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41295879." id="VAR_051807">
<original>G</original>
<variation>S</variation>
<location>
<position position="420"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41298067." id="VAR_051808">
<original>R</original>
<variation>H</variation>
<location>
<position position="677"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only 80% as active as wild-type receptor.">
<original>FSNL</original>
<variation>YTRF</variation>
<location>
<begin position="9"/>
<end position="12"/>
</location>
</feature>
<feature type="mutagenesis site" description="No influence on endocytic uptake of the receptor.">
<original>YTRFSLARQVDGDNS</original>
<variation>PPGYSLARQVDYTRF</variation>
<location>
<begin position="20"/>
<end position="34"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only 16% as active as wild-type receptor." evidence="32">
<original>YTRF</original>
<variation>PPGY</variation>
<location>
<begin position="20"/>
<end position="23"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only 35% as active as wild-type receptor." evidence="25 26 32">
<original>Y</original>
<variation>C</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only 20% as active as wild-type receptor." evidence="25 26 32">
<original>Y</original>
<variation>G</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only 88% as active as wild-type receptor." evidence="32">
<original>T</original>
<variation>F</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only 14% as active as wild-type receptor." evidence="32">
<original>T</original>
<variation>TA</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only 19% as active as wild-type receptor." evidence="32">
<original>T</original>
<variation>TAA</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only 48% as active as wild-type receptor." evidence="32">
<original>F</original>
<variation>Y</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="mutagenesis site" description="2-fold increase of the endocytic uptake of the receptor.">
<original>GDNS</original>
<variation>YTRF</variation>
<location>
<begin position="31"/>
<end position="34"/>
</location>
</feature>
<feature type="mutagenesis site" description="1.27-fold increase of the endocytic uptake of the receptor.">
<original>NADN</original>
<variation>YTRF</variation>
<location>
<begin position="47"/>
<end position="50"/>
</location>
</feature>
<feature type="mutagenesis site" description="20-fold reduced affinity for transferrin receptor. No binding to HFE.">
<original>L</original>
<variation>A</variation>
<location>
<position position="619"/>
</location>
</feature>
<feature type="mutagenesis site" description="No significant effect on binding to transferrin nor HFE.">
<original>V</original>
<variation>A</variation>
<location>
<position position="622"/>
</location>
</feature>
<feature type="mutagenesis site" description="No significant effect on binding to transferrin nor HFE.">
<original>R</original>
<variation>A</variation>
<location>
<position position="623"/>
</location>
</feature>
<feature type="mutagenesis site" description=">5-fold reduced affinity for transferrin. >10-fold reduced affinity for HFE.">
<original>R</original>
<variation>A</variation>
<location>
<position position="629"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on binding to transferrin. >10-fold reduced affinity for HFE.">
<original>Q</original>
<variation>A</variation>
<location>
<position position="640"/>
</location>
</feature>
<feature type="mutagenesis site" description="No significant effect on binding to transferrin nor HFE.">
<original>W</original>
<variation>A</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="mutagenesis site" description="20-fold reduced affinity for transferrin. No binding to HFE.">
<original>Y</original>
<variation>A</variation>
<location>
<position position="643"/>
</location>
</feature>
<feature type="mutagenesis site" description="No significant effect on binding to transferrin nor HFE.">
<original>S</original>
<variation>A</variation>
<location>
<position position="644"/>
</location>
</feature>
<feature type="mutagenesis site" description="No binding to transferrin." evidence="13">
<original>R</original>
<variation>A</variation>
<variation>H</variation>
<location>
<position position="646"/>
</location>
</feature>
<feature type="mutagenesis site" description="5% binding to transferrin." evidence="13">
<original>R</original>
<variation>K</variation>
<location>
<position position="646"/>
</location>
</feature>
<feature type="mutagenesis site" description="Large effect on affinity for transferrin. 4-fold reduced affinity for HFE." evidence="13">
<original>G</original>
<variation>A</variation>
<location>
<position position="647"/>
</location>
</feature>
<feature type="mutagenesis site" description="16% binding to transferrin." evidence="13">
<original>D</original>
<variation>A</variation>
<location>
<position position="648"/>
</location>
</feature>
<feature type="mutagenesis site" description="57% binding to transferrin." evidence="13">
<original>D</original>
<variation>E</variation>
<location>
<position position="648"/>
</location>
</feature>
<feature type="mutagenesis site" description=">5-fold reduced affinity for transferrin. >10-fold reduced affinity for HFE.">
<original>F</original>
<variation>Q</variation>
<location>
<position position="650"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 10; AA sequence." ref="10" evidence="34">
<original>T</original>
<variation>K</variation>
<location>
<position position="104"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 10; AA sequence." ref="10" evidence="34">
<original>R</original>
<variation>V</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 10; AA sequence." ref="10" evidence="34">
<original>Y</original>
<variation>T</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="124"/>
<end position="136"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="140"/>
<end position="146"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="150"/>
<end position="152"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="160"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="179"/>
<end position="192"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="199"/>
<end position="204"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="205"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="209"/>
<end position="214"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="220"/>
<end position="222"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="226"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="232"/>
<end position="234"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="236"/>
<end position="238"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="240"/>
<end position="244"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="245"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="253"/>
<end position="259"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="264"/>
<end position="272"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="273"/>
<end position="275"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="277"/>
<end position="282"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="285"/>
<end position="287"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="303"/>
<end position="306"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="308"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="311"/>
<end position="313"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="317"/>
<end position="319"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="334"/>
<end position="336"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="339"/>
<end position="346"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="349"/>
<end position="352"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="355"/>
<end position="357"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="364"/>
<end position="367"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="371"/>
<end position="377"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="380"/>
<end position="393"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="396"/>
<end position="408"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="411"/>
<end position="413"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="416"/>
<end position="419"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="420"/>
<end position="438"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="445"/>
<end position="455"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="456"/>
<end position="458"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="461"/>
<end position="469"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="470"/>
<end position="473"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="474"/>
<end position="476"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="478"/>
<end position="483"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="491"/>
<end position="498"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="500"/>
<end position="502"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="503"/>
<end position="510"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="516"/>
<end position="518"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="520"/>
<end position="522"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="528"/>
<end position="531"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="541"/>
<end position="546"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="552"/>
<end position="558"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="564"/>
<end position="567"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="573"/>
<end position="579"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="583"/>
<end position="603"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="604"/>
<end position="606"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="613"/>
<end position="625"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="626"/>
<end position="628"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="629"/>
<end position="636"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="640"/>
<end position="662"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="668"/>
<end position="680"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="682"/>
<end position="685"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="688"/>
<end position="690"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="692"/>
<end position="694"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="700"/>
<end position="702"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="705"/>
<end position="708"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="709"/>
<end position="717"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="718"/>
<end position="722"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="728"/>
<end position="749"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="753"/>
<end position="755"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1CX8"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1DE4"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KAS"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3S9L"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3S9M"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3S9N"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62351"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10377239"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10531064"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11702220"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1421756"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1421757"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16325581"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17081065"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17287727"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18268337"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19349973"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2298808"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2327986"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26642240"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3568132"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3582362"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6090955"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6094009"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8408022"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9782058"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<evidence key="35" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="3582362"/>
</source>
</evidence>
<sequence length="760" mass="84871" checksum="C886F14000D90154" modified="2006-05-30" version="2">
MMDQARSAFSNLFGGEPLSYTRFSLARQVDGDNSHVEMKLAVDEEENADNNTKANVTKPK
RCSGSICYGTIAVIVFFLIGFMIGYLGYCKGVEPKTECERLAGTESPVREEPGEDFPAAR
RLYWDDLKRKLSEKLDSTDFTGTIKLLNENSYVPREAGSQKDENLALYVENQFREFKLSK
VWRDQHFVKIQVKDSAQNSVIIVDKNGRLVYLVENPGGYVAYSKAATVTGKLVHANFGTK
KDFEDLYTPVNGSIVIVRAGKITFAEKVANAESLNAIGVLIYMDQTKFPIVNAELSFFGH
AHLGTGDPYTPGFPSFNHTQFPPSRSSGLPNIPVQTISRAAAEKLFGNMEGDCPSDWKTD
STCRMVTSESKNVKLTVSNVLKEIKILNIFGVIKGFVEPDHYVVVGAQRDAWGPGAAKSG
VGTALLLKLAQMFSDMVLKDGFQPSRSIIFASWSAGDFGSVGATEWLEGYLSSLHLKAFT
YINLDKAVLGTSNFKVSASPLLYTLIEKTMQNVKHPVTGQFLYQDSNWASKVEKLTLDNA
AFPFLAYSGIPAVSFCFCEDTDYPYLGTTMDTYKELIERIPELNKVARAAAEVAGQFVIK
LTHDVELNLDYERYNSQLLSFVRDLNQYRADIKEMGLSLQWLYSARGDFFRATSRLTTDF
GNAEKTDRFVMKKLNDRVMRVEYHFLSPYVSPKESPFRHVFWGSGSHTLPALLENLKLRK
QNNGAFNETLFRNQLALATWTIQGAANALSGDVWDIDNEF
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>